These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7879242)

  • 1. Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplant Proc; 1995 Feb; 27(1):948-50. PubMed ID: 7879242
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D; Suc JM
    Nephrol Dial Transplant; 1995; 10 Suppl 6():93-6. PubMed ID: 8524507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: a pilot study.
    Monteon FJ; Contreras AM; Espinoza L; Vazquez G; Aguilar S; Cueva L
    Transplant Proc; 1996 Dec; 28(6):3306-8. PubMed ID: 8962284
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.
    Casanovas Taltavull T; Baliellas C; Sesé E; Iborra MJ; Benasco C; Andrés E; González MT; Gil-Vernet S; Casanova A; Casais LA
    Transplant Proc; 1995 Aug; 27(4):2229-30. PubMed ID: 7652784
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to alpha 2B interferon (IFN) treatment in a haemodialysis patient with chronic hepatitis C.
    Barril G; Schez Tomero JA; Garcia Buey L; Motellon JL; Bernis C; Traver JA
    Nephrol Dial Transplant; 1994; 9(9):1354-5. PubMed ID: 7816309
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha.
    Durlik M; Gaciong Z; Rancewicz Z; Rowińska D; Wyzgał J; Kozłowska B; Gradowska L; Lao M; Nowaczyk M; Korczak-Kowalska G
    Transplant Proc; 1995 Feb; 27(1):958-9. PubMed ID: 7879245
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C.
    Hanafusa T; Ichikawa Y; Kyo M; Fukunishi T; Nagano S; Nakayama K; Nishiuchi M; Ihara H; Fujimoto N; Shinji Y
    Transplant Proc; 1995 Feb; 27(1):956-7. PubMed ID: 7533440
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
    Kamar N; Sandres-Saune K; Selves J; Durand D; Izopet J; Rostaing L
    Nephrologie; 2003; 24(2):89-94. PubMed ID: 12723514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis C with recombinant interferon alpha 2b.
    Terranova R; Luca S
    J Chemother; 1992 Oct; 4(5):297-302. PubMed ID: 1479419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura.
    Yoshida EM; Rock NR; Zeng L; Haniak WA; Anderson FH
    Am J Gastroenterol; 1995 May; 90(5):854-5. PubMed ID: 7605454
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-alpha is effective in the treatment of chronic hepatitis C.
    Worman HJ
    Am J Gastroenterol; 1995 Apr; 90(4):679-80. PubMed ID: 7717348
    [No Abstract]   [Full Text] [Related]  

  • 13. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
    Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
    Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study.
    Therret E; Pol S; Legendre C; Gagnadoux MF; Cavalcanti R; Kreis H
    Transplantation; 1994 Sep; 58(5):625-8. PubMed ID: 7916505
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy.
    Singh N; Gayowski T; Wannstedt CF; Marino IR; Wagener MM
    Clin Transplant; 1996 Aug; 10(4):348-51. PubMed ID: 8884107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal complications during interferon therapy for chronic hepatitis C.
    Kawano T; Shigehira M; Uto H; Nakama T; Kato J; Hayashi K; Maruyama T; Kuribayashi T; Chuman T; Futami T; Tsubouchi H
    Am J Gastroenterol; 1996 Feb; 91(2):309-13. PubMed ID: 8607498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune hepatitis type 1 revealed during treatment with interferon].
    Tran A; Beusnel C; Montoya ML; Lussiez V; Hébuterne X; Rampal P
    Gastroenterol Clin Biol; 1992; 16(8-9):722-3. PubMed ID: 1426834
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
    Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
    Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-interferon for acute hepatitis C in liver transplant patients.
    Vargas V; Charco R; Castells L; Esteban R; Margarit C
    Transplant Proc; 1995 Feb; 27(1):1222-3. PubMed ID: 7533374
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.